Ogeda SA
22Patents
22Active
22Granted
49Portfolio score
Filing activity: Jun 18, 2012 → Oct 8, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9987274B2 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Human Necessities | 3 | Active |
| US9969738B2 | N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Human Necessities | 2 | Active |
| US10065961B2 | Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US9969745B2 | N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Human Necessities | 1 | Active |
| US10683295B2 | Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9695120B2 | Substituted pyrrolidines as G-protein coupled receptor 43 agonists | Chemistry; Metallurgy | 1 | Active |
| US10836768B2 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Chemistry; Metallurgy | 1 | Active |
| US10183948B2 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Chemistry; Metallurgy | 1 | Active |
| US10030025B2 | Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Human Necessities | 1 | Active |
| US9770435B2 | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US12162849B2 | Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-d3 deuterated form thereof | Chemistry; Metallurgy | 0 | Active |
| US10544150B2 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | Human Necessities | 0 | Active |
| US10624890B2 | NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat | Human Necessities | 0 | Active |
| US10941151B2 | Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10214533B2 | N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Human Necessities | 0 | Active |
| US10065960B2 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | Chemistry; Metallurgy | 0 | Active |
| US10017468B2 | Substituted pyrrolidines as G-protein coupled receptor 43 agonists | Chemistry; Metallurgy | 0 | Active |
| US11731974B2 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US11078203B2 | Deuterated fezolinetant | Chemistry; Metallurgy | 0 | Active |
| US9926325B2 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | Human Necessities | 0 | Active |
| US11478472B2 | NK-3 receptor antagonists for therapeutic treatment of leptin-related disease | Human Necessities | 0 | Active |
| US10787458B2 | Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazines | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.